Detalles de la búsqueda
1.
Olaparib in patients with mCRPC with homologous recombination repair gene alterations: PROfound Asian subset analysis.
Jpn J Clin Oncol
; 52(5): 441-448, 2022 May 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35229141
2.
Sample size calculation for recurrent event data with additive rates models.
Pharm Stat
; 21(1): 89-102, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34309179
3.
Prediction of overall survival for patients with metastatic castration-resistant prostate cancer: development of a prognostic model through a crowdsourced challenge with open clinical trial data.
Lancet Oncol
; 18(1): 132-142, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27864015
4.
Phase I dose-escalation study of cabazitaxel administered in combination with gemcitabine in patients with metastatic or unresectable advanced solid malignancies.
Anticancer Drugs
; 26(7): 785-92, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26020806
5.
Consideration of stratification in confirmatory trials with time-to-event endpoint.
Contemp Clin Trials
; 141: 107434, 2024 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38215875
6.
Pembrolizumab with or Without Lenvatinib as First-line Therapy for Patients with Advanced Urothelial Carcinoma (LEAP-011): A Phase 3, Randomized, Double-Blind Trial.
Eur Urol
; 85(3): 229-238, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37778952
7.
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial.
Lancet
; 376(9747): 1147-54, 2010 Oct 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-20888992
8.
Clarification to provide further understanding of the conduct and design of TROPIC: A Phase 3 trial of cabazitaxel versus mitoxantrone in patients with metastatic castration-resistant prostate cancer.
Arch Ital Urol Androl
; 88(1): 72-3, 2016 Mar 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-27072184
9.
Phase I trial of tirapazamine, cisplatin, and concurrent accelerated boost reirradiation in patients with recurrent head and neck cancer.
Int J Radiat Oncol Biol Phys
; 67(3): 678-84, 2007 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17293229
10.
Cabazitaxel Versus Docetaxel As First-Line Therapy for Patients With Metastatic Castration-Resistant Prostate Cancer: A Randomized Phase III Trial-FIRSTANA.
J Clin Oncol
; 35(28): 3189-3197, 2017 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28753384
11.
A DREAM Challenge to Build Prediction Models for Short-Term Discontinuation of Docetaxel in Metastatic Castration-Resistant Prostate Cancer.
JCO Clin Cancer Inform
; 1: 1-15, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30657384
12.
International randomized phase 2 study on the addition of docetaxel to the combination of cisplatin and 5-fluorouracil in the induction treatment for nasopharyngeal carcinoma in children and adolescents.
Cancer Chemother Pharmacol
; 77(2): 289-98, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26666649
13.
A phase I pharmacokinetic and safety study of cabazitaxel in adult cancer patients with normal and impaired renal function.
Cancer Chemother Pharmacol
; 78(6): 1185-1197, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27796539
14.
Analysis of Side Effect Profile of Alopecia, Nail Changes, Peripheral Neuropathy, and Dysgeusia in Prostate Cancer Patients Treated With Docetaxel and Cabazitaxel.
Clin Genitourin Cancer
; 13(4): e205-e208, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25733056
15.
Sequencing of Cabazitaxel and Abiraterone Acetate After Docetaxel in Metastatic Castration-Resistant Prostate Cancer: Treatment Patterns and Clinical Outcomes in Multicenter Community-Based US Oncology Practices.
Clin Genitourin Cancer
; 13(4): 309-318, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25743206
16.
Cabazitaxel Versus Topotecan in Patients with Small-Cell Lung Cancer with Progressive Disease During or After First-Line Platinum-Based Chemotherapy.
J Thorac Oncol
; 10(8): 1221-8, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26200278
17.
Initial biopsy Gleason score as a predictive marker for survival benefit in patients with castration-resistant prostate cancer treated with docetaxel: data from the TAX327 study.
Eur Urol
; 66(2): 330-6, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23957945
18.
An open-label study to investigate the cardiac safety profile of cabazitaxel in patients with advanced solid tumors.
Cancer Chemother Pharmacol
; 73(6): 1241-52, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24718982
19.
Prognostic model predicting metastatic castration-resistant prostate cancer survival in men treated with second-line chemotherapy.
J Natl Cancer Inst
; 105(22): 1729-37, 2013 Nov 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-24136890
20.
[Cabazitaxel for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: the TROPIC study in France]. / Cabazitaxel dans le cancer de la prostate métastatique résistant à la castration ayant progressé pendant ou après traitement par docétaxel : l'expérience française de l'essai TROPIC.
Bull Cancer
; 99(7-8): 731-41, 2012.
Artículo
en Francés
| MEDLINE | ID: mdl-22743148
Resultados
1 -
20
de 20
1
Próxima >
>>